EMA guidance on the use of medicinal products for treatment and prophylaxis in case of exposure to biological agents used as weapons of terrorism, crime or warfare
Consolidated 3-year rolling work plan for the Haematology Working Party (HAEMWP) : January 2025 - December 2027
Consolidated 3-year rolling work plan for the Oncology Working Party : January 2025 - December 2027
Draft 3-year rolling work plan for the Rheumatology and Immunology Working Party (RIWP) : 2025-2027
CAT quarterly highlights and approved ATMPs - May-July 2024
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 July 2024, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2024 to 11 July 2024
Minutes of the PRAC meeting 8-11 July 2024
Veterinary medicines European public assessment report (EPAR): Nobilis Multriva RT+IBm+ND+EDS, avian metapneumovirus, infectious bronchitis virus, Newcastle disease virus and eggdrop syndrome virus vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Nobilis Multriva RT+IBm+ND+Gm+REOm, avian infectious bronchitis,avian reovirus,avian infectious bursal disease,Newcastle disease,Turkey rhinotracheitis virus, Status: Authorised
CTIS newsflash - 10 September 2024